GLP-1 WEIGHT MANAGEMENT PROBIOTICS
Click here for Cleveland Clinic information regarding Saxenda CONTRAVE (buproprion/naltrexone) Drug identification number (DIN): 02472945 Contrave is a tablet taken twice daily that combines low doses of naltrexone, a medication used to help treat alcohol or opioid dependency, and bupropion (Wellbutrin), an antidepressant thats also used for smoking cessation (Zyban)
Benefits for People With Type 2 Diabetes People with type 2 diabetes saw two noticeable improvements: Lower blood sugar levels , including meaningful HbA1c reductions Steady weight loss , though typically a little less than non-diabetic participants a pattern also seen with injected GLP-1 receptor agonists The blood sugar improvements reflect how GLP-1 receptor agonists support insulin activity and slow digestion, which may help stabilise glucose throughout the day
There have been reports of gallbladder disease , including cholelithiasis (gallstones) and cholecystitis, possibly related to rapid weight loss
indicated he is working to overturn the 2023 FDA decision that banned compounding pharmacies from producing certain peptides listed in Category 2
This content has been authored or reviewed and approved by Maria Atkins, DO, or her staff.